A Physician Prescribes. The Pharmacy Decides Whether It Can Lawfully Fill.

Medical judgment and pharmacy compliance are separate responsibilities

When a physician determines that a patient needs a particular medication, the physician should be free to treat that patient according to the physician’s medical judgment and the applicable standard of care.

The physician’s responsibility is to evaluate the patient, identify a legitimate medical need, select an appropriate treatment, explain the material risks and alternatives, and document the decision.

The pharmacy has a different responsibility.

Before compounding and dispensing the medication, the pharmacy must determine whether it has a lawful regulatory pathway to do so.

These are separate legal duties. A physician’s prescription does not relieve the pharmacy of its compliance obligations, and a pharmacy should not shift responsibility for an unlawful fill back onto the prescriber.

A Prescription Is Not an Order to Violate the Law

A pharmacist is not required to fill every prescription presented by a physician.

Pharmacies routinely review prescriptions for validity, dosing, contraindications, drug interactions, controlled-substance requirements, compounding restrictions, and other legal or safety concerns. When a pharmacy cannot lawfully fill a prescription, the pharmacy must decline it or contact the prescriber to discuss a lawful alternative.

That same principle applies to compounded medications.

If a physician prescribes tirzepatide because the physician concludes that it is medically appropriate for the patient, the pharmacy must independently determine whether it may dispense an FDA-approved tirzepatide product or whether a lawful basis exists to prepare a compounded version.

The pharmacy cannot lawfully compound a restricted product merely because a physician prescribed it. The prescription establishes medical authorization to treat the patient. It does not create regulatory authorization for the pharmacy to manufacture the drug.

The Pharmacy Bears Primary Responsibility for the Fill

A compounding pharmacy is responsible for understanding and complying with the laws that govern its operations, including:

• Whether it is operating under Section 503A or Section 503B.

• Whether the prescribed medication is commercially available.

• Whether the drug is on FDA’s shortage list.

• Whether the product would be considered essentially a copy of an approved drug.

• Whether the active pharmaceutical ingredient may lawfully be used.

• Whether the pharmacy may dispense the product to an individual patient or distribute it for office use.

• Whether the product satisfies applicable sterility, testing, labeling, sourcing, and state pharmacy requirements.

  
  

These are pharmacy compliance questions. A physician should not be expected to conduct the pharmacy’s legal analysis, inspect its cleanroom, verify every batch record, or independently audit its ingredient suppliers before writing every prescription.

A physician may reasonably expect a licensed pharmacy to understand the laws governing its own compounding and dispensing activities.

If the pharmacy receives a prescription that it cannot lawfully fill, the pharmacy should reject the prescription, request additional patient-specific information, or explain what lawful alternatives are available. It should not fill the prescription and then argue that the physician assumed responsibility merely by signing it.

The Tirzepatide Example

Assume a physician evaluates a patient and concludes that tirzepatide is medically appropriate. The physician documents the patient’s condition, treatment history, clinical goals, contraindications, risks, and anticipated benefits.

That is a medical decision.

If the prescription is sent to a compounding pharmacy, the pharmacy must determine whether it has a lawful basis to compound tirzepatide. Because tirzepatide is no longer on FDA’s drug-shortage list, the pharmacy generally cannot operate a standardized program that produces routine copies of Mounjaro or Zepbound.

A 503A pharmacy may evaluate whether a patient-specific change produces a significant difference for the identified patient. The prescriber has an important role in making and documenting that clinical determination. But the pharmacy remains responsible for deciding whether the prescription and proposed formulation satisfy all conditions necessary for the pharmacy to compound and dispense the product.

A pharmacy cannot convert an unlawful standardized compounding program into a lawful one simply by obtaining physician signatures.

FDA’s September 18, 2026 warning letter to Empower Pharmacy reinforces this distinction. FDA directed the enforcement action at the pharmacy, while also questioning prescriptions that lacked individualized significant-difference determinations or used repetitive, pre-generated language.

When Could the Physician Still Face Exposure?

The physician is not automatically responsible simply because a pharmacy improperly fills a medically appropriate prescription.

The physician remains responsible for the physician’s own conduct. Exposure can increase if the physician:

• Prescribes without an adequate examination or legitimate medical indication.

• Fails to document the clinical basis for treatment.

• Makes a significant-difference determination that is not medically genuine.

• Signs pharmacy-generated boilerplate without exercising independent judgment.

• Knows the pharmacy lacks a lawful pathway but actively helps conceal or circumvent that problem.

• Markets a standardized compounded-drug program using misleading claims.

• Receives improper compensation tied to prescriptions or pharmacy referrals.

• Purchases, resells, dispenses, or administers products despite known regulatory or safety concerns.

• Continues using a pharmacy after learning of serious sourcing, sterility, licensing, or enforcement problems.

  
  

Those circumstances involve more than prescribing medically necessary treatment. They may show that the physician participated in the pharmacy’s regulatory violation or independently departed from the applicable standard of care.

Physicians Should Practice Medicine

Physicians should not allow uncertainty in the compounding market to prevent them from exercising legitimate medical judgment.

If a patient needs tirzepatide, the physician should be able to determine that tirzepatide is medically appropriate and prescribe it. The physician should document the medical reasoning and identify any patient-specific formulation requirements.

The pharmacy must then determine whether it can lawfully fill that prescription and in what form.

The physician owns the medical decision. The pharmacy owns the compounding and dispensing decision.

The prescription is not a guarantee that the pharmacy may legally manufacture the product. It is the starting point for the pharmacy’s independent compliance analysis.

When each party stays within its proper role, the physician can focus on treating the patient while the pharmacy remains accountable for understanding and following the laws governing its own operations.

This article provides general information and does not constitute legal advice. The respective responsibilities of prescribers, pharmacies, clinics, and outsourcing facilities depend on the product, jurisdiction, contractual relationships, and specific conduct involved.